Babich, John W,Zimmerman, Craig,Joyal, John,Lu, Genliang
申请号：
AU2014205304
公开号：
AU2014205304B2
申请日:
2014.01.10
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Compounds according to Formula (I) and Formula (II) are potent inhibitors of PSMA. (I) or (II) Pharmaceutical compositions may include a complex of a radionuclide and a Formula (I) compound or a Formula (II) compound. Methods include using the radionuclide complex of a Formula (I) compound or a Formula (II) compound for treating or diagnosis of a disease or a condition associated with PSMA activity.
